Author

A. Cagigi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Organism:rat· 2 Organism:mouse· 1

Frequent Co-Authors

J. R. Mascola· 3 shared A. B. McDermott· 2 shared B. S. Graham· 2 shared J. C. Boyington· 2 shared K. S. Corbett· 2 shared M. C. Crank· 2 shared M. Kanekiyo· 2 shared P. D. Kwong· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

J. R. Mascola

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Cell targeting and immunostimulatory properties of a novel Fcγ-receptor independent agonistic anti-CD40 antibody in rhesus macaques

X. Yan, S. Ols, R. Arcoverde Cerveira, K. Lenart, F. Hellgren, K. Ye, A. Cagigi, M. Buggert, F. Nimmerjahn, J. Falkesgaard Hojen, D. Parera, U. Pessara, S. Fischer, K. Lore

This study introduces an Fcγ-receptor independent agonistic anti-CD40 antibody that activates immune cells in vitro and in vivo in rhesus macaques, showing potential as an immunostimulatory adjuvant.

bioRxiv · Mar 22, 2023Immunology

Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings

K. L. Boswell, T. Watkins, E. M. Cale, J. Samsel, S. F. Andrews, D. R. Ambrozak, J. I. Driscoll, M. A. Messina, S. Narpala, C. S. Hopp, A. Cagigi, J. P. Casazza, T. Yamamoto, T. Zhou, W. R. Schief, , R. A. Koup

This study applies Bcl-6/Bcl-xL retroviral transduction to isolate antibodies and generate B cell clones from various B cell populations in healthy and infected individuals.

bioRxiv · Mar 29, 2022Immunology

Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses

S. M. Moin, J. C. Boyington, S. Boyoglu-Barnum, R. A. Gillespie, G. Cerutti, C. S.-F. Cheung, A. Cagigi, J. R. Gallagher, J. Brand, M. Prabhakaran, Y. Tsybovsky, T. Stephens, B. E. Fisher, A. Creanga, S. Ataca, , M. Kanekiyo

This study shows that co-immunization with stem immunogens from group 1 and 2 influenza A HAs elicits cross-group neutralizing antibodies and protective immunity in multiple animal models.

bioRxiv · Feb 11, 2022 · PreprintImmunology

Design of nanoparticulate group 2 influenza hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages

K. S. Corbett, S. M. Moin, H. M. Yassine, A. Cagigi, M. Kanekiyo, S. Boyoglu-Barnum, S. I. Myers, Y. Tsybovsky, A. K. Wheatley, C. A. Schramm, R. A. Gillespie, W. Shi, L. Wang, Y. Zhang, S. F. Andrews, , J. C. Boyington

This study designs nanoparticle-based influenza HA stem antigens that activate unmutated B cell receptors of broadly neutralizing antibodies, potentially enabling cross-group immunity.

bioRxiv · Dec 17, 2018Immunology